The following sections summarize the available evidence about lactoferrin’s therapeutic effectiveness toward different diseases, such as gastroenteric diseases, neonatal sepsis, and necrotizing enterocolitis, lung diseases, and COVID-19. The gene discussed is LTF; the disease is necrotizing enterocolitis.